Accu-Chek Aviva Plus Blood Glucose Monitoring System
Glucose Dehydrogenase, Glucose. 510(k) K101299, from Roche Diagnostics (Indianapolis, IN). Product code LFR, class 2.
As of Nov 18, 2026, K101299 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Sep 21, 2011 after 499 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Sep 21, 2011
- Review time: 499 days
- Recalls: 0
- Cited as a predicate by: 5 devices
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe ACCU-CHEK Aviva Plus Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, forearm, upper arm, or palm. The ACCU-CHEK Aviva Plus Blood Glucose Monitoring System is intended to be used by a single person and should not be shared.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Accu-Chek Aviva Test StripsK060620 · Roche Diagnostics Corp. · Aug 11, 2006
- Accu-Chek Aviva SystemK043474 · Roche Diagnostics Corp. · Apr 27, 2005
Cited as a Predicate
5 later 510(k) summaries name this device as a predicate- Accu-Chek Aviva Connect Blood Glucose Monitoring SystemK141867 · Roche Diagnostics · Mar 3, 2015
- Accu-Chek Aviva Plus SystemK133862 · Roche Diagnostics Corporation · Apr 29, 2014
- Accu-Chek Aviva Plus Test StripK131029 · Roche Diagnostics Operations, Inc. · Aug 9, 2013
- Glucose Test SystemK113137 · Roche Diagnostics · Jan 6, 2012
- Accu-Check Combo SystemK111353 · Roche Diagnostics · Jul 17, 2012
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 10, 2010
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files